IBA

IBA, or Ion Beam Applications, is a high-technology healthcare company and a worldwide provider of proton therapy technology. Drawing on decades of experience, the company works with healthcare customers and partners to help make proton therapy available to patients who may benefit from it. IBA reports that more than 140,000 patients have been treated using its equipment, within a global total of over 400,000 patients treated with proton beam therapy.

Its offerings include Proteus proton therapy systems, such as ProteusONE and ProteusPLUS, designed to support clinical care and research at oncology centers. The systems use precise, image-guided, intensity-modulated proton beams. IBA also presents DynamicARC and ConformalFLASH as proton therapy innovations in research and development; they are not available for sale until regulatory clearance is received. Related technologies include motion management.

Beyond equipment, IBA provides services across the center lifecycle, including building, training, commissioning, first-patient support, maintenance, and upgrades. The company also shares information about proton therapy, medical indications, treatment centers, and professional events, and fosters collaboration across the proton therapy community.